TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biognos AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
12
|
96 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-110
|
-116
|
-27 |
| EBITDA |
-109
|
-114
|
-24 |
| Total assets |
54
|
52
|
51 |
| Current assets |
54
|
52
|
48 |
| Current liabilities |
38
|
34
|
42 |
| Equity capital |
17
|
18
|
9 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
31.5%
|
34.6%
|
17.6% |
| Turnover per employee |
0
|
12
|
96 |
| Profit as a percentage of turnover |
-966.7%
|
-28.1% | |
| Return on assets (ROA) |
-203.7%
|
-223.1%
|
-52.9% |
| Current ratio |
142.1%
|
152.9%
|
114.3% |
| Return on equity (ROE) |
-647.1%
|
-644.4%
|
-300% |
| Change turnover |
-12
|
-76
|
1 |
| Change turnover % |
-100%
|
-87%
|
1% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.